Oscar Health, Inc. (NYSE:OSCR) Given Consensus Recommendation of "Strong Sell" by Analysts

Key Points

• Oscar Health, Inc. has been given a consensus recommendation of "Strong Sell" by analysts, with six analysts recommending to sell and four recommending to hold the stock.
• The average twelve-month price target for Oscar Health is $12.64, while shares recently opened at $20.36, showcasing significant market fluctuation.
• Insider Mario Schlosser sold 395,000 shares of Oscar Health stock, which represents a 44.08% decrease in their position, indicating a potential lack of confidence in the company's future performance.

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) has been assigned an average recommendation of "Strong Sell" from the ten ratings firms that are presently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a sell recommendation and four have given a hold recommendation to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $12.6429.

Several research analysts have recently issued reports on OSCR shares. Raymond James Financial lowered Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Piper Sandler decreased their target price on Oscar Health from $14.00 to $13.00 and set a "neutral" rating for the company in a research report on Thursday, August 14th. Wells Fargo & Company increased their target price on Oscar Health from $10.00 to $14.00 and gave the stock an "underweight" rating in a research report on Tuesday, October 7th. Barclays decreased their target price on Oscar Health from $17.00 to $11.00 and set an "underweight" rating for the company in a research report on Wednesday, July 23rd. Finally, Robert W. Baird reiterated a "neutral" rating and set a $14.00 price objective (down previously from $28.00) on shares of Oscar Health in a research note on Friday, July 25th.

Oscar Health Trading Up 8.5%

NYSE OSCR opened at $20.36 on Tuesday. Oscar Health has a fifty-two week low of $11.20 and a fifty-two week high of $23.80. The stock has a market cap of $5.27 billion, a P/E ratio of -25.14 and a beta of 1.89. The stock has a 50 day simple moving average of $17.90 and a two-hundred day simple moving average of $15.93. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.90) by $0.01. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The firm had revenue of $2.86 billion during the quarter, compared to analyst estimates of $2.88 billion. During the same quarter in the prior year, the company earned $0.20 EPS. The business's revenue was up 29.0% compared to the same quarter last year. On average, analysts forecast that Oscar Health will post 0.69 earnings per share for the current year.

Insider Activity at Oscar Health

In other Oscar Health news, insider Mario Schlosser sold 395,000 shares of Oscar Health stock in a transaction on Monday, September 22nd. The stock was sold at an average price of $18.43, for a total value of $7,279,850.00. Following the completion of the sale, the insider owned 501,148 shares of the company's stock, valued at approximately $9,236,157.64. This trade represents a 44.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 25.11% of the company's stock.

Hedge Funds Weigh In On Oscar Health

A number of institutional investors and hedge funds have recently modified their holdings of OSCR. LRI Investments LLC boosted its stake in shares of Oscar Health by 377.9% in the 2nd quarter. LRI Investments LLC now owns 1,233 shares of the company's stock worth $26,000 after buying an additional 975 shares during the last quarter. Jones Financial Companies Lllp lifted its position in Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock valued at $30,000 after purchasing an additional 2,242 shares in the last quarter. Strs Ohio purchased a new position in Oscar Health during the first quarter valued at $30,000. Larson Financial Group LLC lifted its position in Oscar Health by 83,733.3% during the first quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock valued at $33,000 after purchasing an additional 2,512 shares in the last quarter. Finally, Atlantic Union Bankshares Corp purchased a new position in Oscar Health during the second quarter valued at $33,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.